NICE Guidelines: management of colorectal cancer metastases

@article{Baum2020NICEGM,
  title={NICE Guidelines: management of colorectal cancer metastases},
  author={M. Baum and L. Fallowfield and V. Farewell and F. Macbeth and T. Treasure},
  journal={British Journal of Surgery},
  year={2020},
  volume={107}
}
Editor The NICE recommendations to ‘consider’ surgical resection for colorectal cancer (CRC) metastases should worry those who value evidence-informing surgical practice1. There are no randomized controlled trials (RCT) of liver metastasectomy primarily due to liver surgeons’ opposition2. The effectiveness of peritoneal cytoreductive surgery (CRS) could not be deduced from the RCTs cited, because it was in both arms1. The evidence given supporting lung metastasectomy is poor: one retrospective… Expand
1 Citations

References

SHOWING 1-8 OF 8 REFERENCES
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
  • 123
  • PDF
RE: Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.
  • 34
  • PDF
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed
  • 24